Literature DB >> 8884369

Immunization strategy for prevention of congenital cytomegalovirus infection.

R F Pass1.   

Abstract

Women of childbearing age are a logical target for a vaccine aimed at prevention of congenital cytomegalovirus (CMV) infections. However, the impact of a CMV vaccine could likely be enhanced by considering the sources of maternal infection and characteristics of mothers of infected newborns. Contact with preschool-age children and sexual activity are important sources of CMV infection for young women. Approximately half of infants with congenital CMV infection in the U.S. are born to unmarried, adolescent mothers. To prevent CMV infection in those who are the sources of maternal infection as well as in young, unmarried mothers, universal immunization of toddlers and preteen children should be considered.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8884369

Source DB:  PubMed          Journal:  Infect Agents Dis        ISSN: 1056-2044


  11 in total

Review 1.  Cytomegalovirus antivirals and development of improved animal models.

Authors:  Alistair McGregor; K Yeon Choi
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-09-01       Impact factor: 4.481

2.  Importance of Highly Conserved Peptide Sites of Human Cytomegalovirus gO for Formation of the gH/gL/gO Complex.

Authors:  Cora Stegmann; Mohamed E A Abdellatif; Kerstin Laib Sampaio; Paul Walther; Christian Sinzger
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

3.  Endothelial Cell Infection by Guinea Pig Cytomegalovirus Is a Lytic or Persistent Infection Depending on Tissue Origin but Requires Viral Pentamer Complex and pp65 Tegument Protein.

Authors:  K Yeon Choi; Nadia El-Hamdi; Alistair McGregor
Journal:  J Virol       Date:  2022-08-24       Impact factor: 6.549

Review 4.  Congenital cytomegalovirus infection.

Authors:  Alexander K C Leung; Reginald S Sauve; H Dele Davies
Journal:  J Natl Med Assoc       Date:  2003-03       Impact factor: 1.798

5.  A Novel Non-Replication-Competent Cytomegalovirus Capsid Mutant Vaccine Strategy Is Effective in Reducing Congenital Infection.

Authors:  K Yeon Choi; Matthew Root; Alistair McGregor
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

Review 6.  Cytomegalovirus vaccine development.

Authors:  M R Schleiss
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

7.  Guinea pig cytomegalovirus protective T cell antigen GP83 is a functional pp65 homolog for innate immune evasion and pentamer dependent virus tropism.

Authors:  K Yeon Choi; Nadia El-Hamdi; Julia Hornig; Alistair McGregor
Journal:  J Virol       Date:  2021-03-03       Impact factor: 5.103

8.  Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus.

Authors:  Jie Zhong; Michael Rist; Leanne Cooper; Corey Smith; Rajiv Khanna
Journal:  PLoS One       Date:  2008-09-22       Impact factor: 3.240

9.  A Homolog Pentameric Complex Dictates Viral Epithelial Tropism, Pathogenicity and Congenital Infection Rate in Guinea Pig Cytomegalovirus.

Authors:  Stewart Coleman; K Yeon Choi; Matthew Root; Alistair McGregor
Journal:  PLoS Pathog       Date:  2016-07-07       Impact factor: 6.823

10.  Natural killer cells attenuate cytomegalovirus-induced hearing loss in mice.

Authors:  Ali A Almishaal; Pranav D Mathur; Elaine Hillas; Liting Chen; Anne Zhang; Jun Yang; Yong Wang; Wayne M Yokoyama; Matthew A Firpo; Albert H Park
Journal:  PLoS Pathog       Date:  2017-08-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.